Safety and Efficacy of Left Atrial Appendage Occlusion Devices



Status:Completed
Conditions:Atrial Fibrillation
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - Any
Updated:5/25/2018
Start Date:May 2012
End Date:February 2018

Use our guide to learn which trials are right for you!

Comparison of Safety and Efficacy of Left Atrial Appendage Occlusion Devices

Atrial fibrillation (AF) is the most common cardiac rhythm disorder in clinical practice. In
the last two decades the number of hospitalizations for AF has increased two- to three-fold.
More than 6 million people worldwide suffer from atrial fibrillation (AF), a cardiac disorder
that results in systemic emboli. Patients with AF are 5 times more likely to have a stroke
compared with those without AF.

This registry will collection information on two devices that are used to treat AF. The
WATCHMAN and LARIAT. The differences in techniques and subsequent effects of the two devices
on outcomes related to AF has not been studied. This study will look to compare the two
devices to see how the outcomes may vary.


Inclusion Criteria:

- Patients who have had a LARIAT LAA device occlusion

Exclusion Criteria:

- Patients who have PFO/ASD/critical carotid artery (>70% blockage) disease and
hemorrhagic strokes
We found this trial at
1
site
3901 Rainbow Blvd
Kansas City, Kansas 66160
(913) 588-5000
University of Kansas Medical Center The University of Kansas Medical Center serves Kansas through excellence...
?
mi
from
Kansas City, KS
Click here to add this to my saved trials